Amanote Research

Amanote Research

  • Register
  • Sign In

Twenty Years Later: Has Cell of Origin Testing in Diffuse Large B Cell Lymphoma Run Its Course?

Journal of Hematopathology- Germany

doi 10.1007/s12308-020-00390-z

Full Text

Abstract

Available in

Categories

Forensic MedicinePathologyHematologyHistology

Date

February 28, 2020

Authors

William R. Macon

Publisher

Springer Science and Business Media LLC


Related search

Diffuse Large B-Cell Lymphoma

2020English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type

Acta Dermato-Venereologica
DermatologyMedicine
2016English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

PKC-beta II Expression Has Prognostic Impact in Nodal Diffuse Large B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy